Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer. This drug was developed by OncoMed…
Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer.
This drug was developed by OncoMed Pharmaceuticals.Statement On A Nonproprietary Name Adopted By The USAN Council - Rosmantuzumab, American Medical Association.
References
Gebaseerd op: Wikipedia — Rosmantuzumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.